Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (52)
  • Open Access

    ARTICLE

    Correlation between Syndecan-1 in Inter Category of RACHS-1 Score and Immediate Clinical Outcomes

    Novik Budiwardhana1,*, Indah Kartika Murni2, Eva Miranda Marwali1, Pribadi Wiranda Busro3, Fildza Intan Rizkia4, Muhamad Faza Soelaeman4, Yunita Widyastuti5

    Congenital Heart Disease, Vol.20, No.5, pp. 591-600, 2025, DOI:10.32604/chd.2025.070345 - 30 November 2025

    Abstract Background: Low cardiac output syndrome (LCOS) is a frequent and serious complication after pediatric cardiac surgery. Endothelial glycocalyx (EG) degradation, indicated by elevated syndecan-1, contributes to microvascular dysfunction and postoperative instability. The relationship between syndecan-1 dynamics and surgical risk categories remains unclear. Objective: To examine the association between perioperative syndecan-1 levels and clinical outcomes across Risk Adjustment for Congenital Heart Surgery (RACHS-1) categories. Methods: We analyzed 106 children (RACHS-1 categories 2–4) undergoing elective cardiac surgery with cardiopulmonary bypass (CPB). Syndecan-1 was measured at baseline (T0), 4 h (T4), and 72 h (T72). Outcomes included LCOS, vasoactive inotropic… More >

  • Open Access

    ARTICLE

    Endothelin-1 Mediates Oxaliplatin Resistance via Activation of YAP Signaling in Colorectal Cancer

    Ranran Yang1,2,3,#, Dan Yuan2,#, Chaohan Liang4,#, Siying Zhu4, Jie Huang2, Yingqi Zhang4, Weiling He5, Qinghai Li1,*, Hong Zhang2,*

    Oncology Research, Vol.33, No.12, pp. 3945-3971, 2025, DOI:10.32604/or.2025.064463 - 27 November 2025

    Abstract Background: Colorectal cancer (CRC) is a predominant contributor to global cancer-associated mortality worldwide. Oxaliplatin (OXP), a foundational chemotherapeutic agent for CRC, often exhibits limited efficacy due to the emergence of drug resistance. Although endothelin-1 (EDN1) has been implicated in tumor drug resistance, its role in oxaliplatin resistance in CRC remains poorly defined. This work aimed to define how EDN1 contributes to oxaliplatin resistance and to explore its potential as a therapeutic target. Methods: Public genomic datasets were analyzed to confirm EDN1 upregulation in colorectal cancer (CRC) and its association with poor prognosis. EDN1 expression was… More >

  • Open Access

    ARTICLE

    Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2V617F mutation in myeloproliferative neoplasms

    MOHAMMAD ABOHASSAN, MESFER MOHAMMAD AL SHAHRANI, SARAH KHALED ALOUDA, PRASANNA RAJAGOPALAN*

    Oncology Research, Vol.33, No.3, pp. 675-685, 2025, DOI:10.32604/or.2024.056256 - 28 February 2025

    Abstract Background: The JAK2V617F mutation plays a crucial part in the pathogenesis of myeloproliferative neoplasms (MPN), which includes polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) leading to aberrant proliferation and survival of hematopoietic cells. Alongside the challenges of drug resistance and side effects, identifying novel compounds that selectively target JAK2V617F could provide more effective and safer therapeutic options for patients with MPNs. Materials and Methods: We employed computational approaches like high-throughput virtual screening, molecular dynamics simulations (MDS), and binding free energy calculations to identify inhibitors targeting wild and mutant JAK2 kinases. JAK2V617F positive HEL, wild… More >

  • Open Access

    ARTICLE

    MiR-30a-5p alleviates LPS-induced HPMEC injury through regulation of autophagy via Beclin-1

    RAN PAN1,#, JIAYAN MAO2,#, YUELIANG ZHENG3, WEI CHEN2, JUNPING GUO1,*, LIJUN WANG3,*

    BIOCELL, Vol.48, No.3, pp. 431-441, 2024, DOI:10.32604/biocell.2023.046484 - 15 March 2024

    Abstract Background: Sepsis, a type of systemic disease, can impact nearly all organs, tissues and cells. Among them, endothelial cells are amongst the first to be affected and respond to the insult. In this study, we investigated the protective effects of microRNA-30a-5p (miR-30a-5p) on human pulmonary microvascular endothelial cells (HPMECs) treated with lipolysaccharide (LPS). Methods: An in vitro model of sepsis was established in HPMECs with the use of LPS. Transfecting with different tools (mimetic and inhibitor) to modify miR-30a-5p expression. Cell viability, proliferation and apoptosis were detected by the CCK-8 assay, the EdU kit and fluorescence… More >

  • Open Access

    ARTICLE

    Knowledge-Based Efficient N-1 Analysis Calculation Method for Urban Distribution Networks with CIM File Data

    Lingyu Liang1, Xiangyu Zhao1,*, Wenqi Huang1, Liming Sun2,3, Ziyao Wang3, Yaosen Zhan2

    Energy Engineering, Vol.120, No.12, pp. 2839-2856, 2023, DOI:10.32604/ee.2023.042042 - 29 November 2023

    Abstract The N-1 criterion is a critical factor for ensuring the reliable and resilient operation of electric power distribution networks. However, the increasing complexity of distribution networks and the associated growth in data size have created a significant challenge for distribution network planners. To address this issue, we propose a fast N-1 verification procedure for urban distribution networks that combines CIM file data analysis with MILP-based mathematical modeling. Our proposed method leverages the principles of CIM file analysis for distribution network N-1 analysis. We develop a mathematical model of distribution networks based on CIM data and… More >

  • Open Access

    REVIEW

    Interleukin-1 receptor antagonist: From synthesis to therapeutic applications

    KANWAL REHMAN1, AMMARA AFZAAL2, MUHAMMAD SAJID HAMID AKASH2,*, MUHAMMAD IMRAN3,4, MOHAMMED A. ASSIRI3,4

    BIOCELL, Vol.47, No.4, pp. 809-823, 2023, DOI:10.32604/biocell.2023.025850 - 08 March 2023

    Abstract The cytokine channel’s mechanism for self-regulation involves the application of antagonistic cytokines that are synthesized to connect to the receptors and release soluble cytokine receptors. The very first receptor antagonist of cytokine that was naturally present was interleukin-1 receptor antagonist (IL-1Ra). The IL-1Ra protein forms are disinfected from supernatants of cultured monocytes on stacked IgG. The family of IL-1 consists of IL-1α, IL-1β and IL-1Ra. Human monocytes regulate the production of IL-Ra. IL-Ra takes part in normal physiological functions by using specific antibodies, and acts as an anti-inflammatory agent. IL-Ra is synthesized in the tissues More >

  • Open Access

    ARTICLE

    AKT regulates IL-1β-induced proliferation and activation of hepatic stellate cells

    YONGDAE YOON1,#, SOONJAE HWANG1,2,#, FATEMA TUJ SAIMA3,#, MOON YOUNG KIM1,3,4, SOON KOO BAIK1,3,4,*, YOUNG WOO EOM1,3,*

    BIOCELL, Vol.47, No.3, pp. 669-676, 2023, DOI:10.32604/biocell.2023.025365 - 03 January 2023

    Abstract Background: Activated hepatic stellate cells (HSCs) are closely involved in the initiation, perpetuation, and resolution of liver fibrosis. Pro-inflammatory cytokine levels are positively correlated with the transition from liver injury to fibrogenesis and contribute to HSC pathophysiology in liver fibrosis. Methods: In this study, we investigated the effect of the pro-inflammatory cytokine interleukin (IL)-1β on the proliferation and signaling pathways involved in fibrogenesis in LX-2 cells, an HSC cell line, using western blotting and cell proliferation assays. Results: IL-1β increased the proliferation rate and α-smooth muscle actin (SMA) expression of LX-2 cells in a dose-dependent manner. Within… More >

  • Open Access

    ARTICLE

    Heparanase/Syndecan-1 Axis Regulates the Grade of Liver Cancer and Proliferative Ability of Hepatocellular Carcinoma Cells

    Shengjin Yu, Huiming Lv, Jinhui Zhang, He Zhang, Weiwei Ju, Yu Jiang*, Lijuan Lin*

    Oncologie, Vol.24, No.3, pp. 539-551, 2022, DOI:10.32604/oncologie.2022.024882 - 19 September 2022

    Abstract Background: Although heparanase/syndecan-1 axis is involved in malignant progression of many cancers, its significance in liver cancer is not well understood. In this study, we explored the value of heparanase/syndecan-1 axis expression in liver cancer and the intervention mechanisms that target this axis by inhibiting the proliferation of hepatocellular carcinoma cells. Materials and Methods: We conducted tissue microarray analysis that included 90 primary liver cancer and their corresponding adjacent samples to evaluate the expression of heparanase and syndecan-1 and their correlation with clinicopathologic characteristics. RNA interference and western blot assays were performed to analyze the effect of… More >

  • Open Access

    ARTICLE

    A potential impact of A Disintegrin and Metalloproteinase DomainLike Protein Decysin-1 (ADAMDEC1) on clear cell renal cell carcinoma propagation

    MAGDALENA RUDZIŃSKA-RADECKA*

    BIOCELL, Vol.46, No.8, pp. 1893-1901, 2022, DOI:10.32604/biocell.2022.019724 - 22 April 2022

    Abstract Clear cell renal cell carcinoma (KIRC) is the most common and aggressive malignancy subtype of renal neoplasm that arises from proximal convoluted tubules. It is characterized by poor clinical outcomes and high mortality of patients due to the lack of specific biomarkers for varying stages of the disease and no effective treatment. Proteases are associated with the development of several malignant tumors in humans by their ability to degrade extracellular matrices, facilitating metastasis. Herein, differentially expressed genes in KIRC cases compared to healthy kidneys were screened out from the Gene Expression Profiling Interactive Analysis (GEPIA)… More >

  • Open Access

    ARTICLE

    Astaxanthin delayed the pathogenesis of diabetic nephropathy in type 1 diabetic rats

    LIANHUAN MA1, SHOUPENG LIU2, XIAOWEN ZHEN1, WEIWEI QIAO1, LINA MA1, XIAOMIN ZHANG3,*

    BIOCELL, Vol.46, No.8, pp. 1911-1916, 2022, DOI:10.32604/biocell.2022.019277 - 22 April 2022

    Abstract This study was designed to investigate the protective effects of Astaxanthin (AST) in rats with diabetes mellitus (DM) induced by streptozotocin. SD rats were divided into control group (n = 5, only received normal saline), DM group (n = 8) and AST + DM group (n = 8; AST: 50 mg/kg/day). DM rats were induced by intraperitoneal injection of streptozocin (STZ, 65 mg/kg). Blood glucose level and body weight were determined at weeks 0, 2, 4, 6 and 8, respectively. At week 8, kidney function was determined, together with expression of P53 and dynamin-related protein-1 More >

Displaying 1-10 on page 1 of 52. Per Page